Analysis of Respiratory Mechanics in Patients With Rheumatoid Arthritis

Hospital Universitario Pedro Ernesto

Status: Unknown

Conditions: Rheumatoid Arthritis

Study type: Observational

Funder types: Other

Identifiers

NCT01641705

AR-01

Details and patient eligibility

About

Rheumatoid arthritis (RA) is an autoimmune disease of unknown etiology characterized by peripheral polyarthritis, symmetric, which leads to joint destruction and deformity. It is estimated that the RA reaches about 0.5% of the population. According to data from DATASUS, was responsible for 26,671 hospitalizations, 229 deaths and cost exceeding R$ 20 million in 2005-2007.

The main bodily changes are related to joint problems, however, systemic manifestations are also found in organs such as lung and heart. Although cardiovascular diseases are the most responsible of the deaths AR, pulmonary complications are common and account for 10% to 15% of all mortality. Anaya and colleagues point out that the pulmonary involvement contributes significant morbidity and mortality in these patients. Although pulmonary involvement is a frequent manifestation in RA, the prevalence and nature of rheumatoid lung disease has not yet been precisely established. Several lung disorders such as interstitial pulmonary fibrosis, pulmonary nodules and bronchiolitis may ocorrer1. Laitinen et al point out that studies of lung function appear to be a valuable helper for radiography in the evaluation of pulmonary involvement in connective tissue diseases. Previous studies indicate that patients with RA have an increased incidence of abnormal lung function, according to assessments including spirometry, lung volume tests and diffusion capacity of carbon monoxide.

Thus, the main objective of this study is to analyze the respiratory mechanics of patients with RA. Specific objectives were to seek to understand whether a relationship exists between duration of rheumatoid disease and lung function in these patients.

For this, the investigators used 18 subjects in the control group, free of pulmonary disease and / or heart, all nonsmokers. In the RA group, a total of 72 patients divided into 4 groups of 18 volunteers each, classified according to disease duration (0-5 years, 6-10 years, 11-15 years and> or = 16 years). It is noteworthy that all patients in the RA group will also be non-smokers, since it is already known in the literature that smoking impairs lung function. All individuals will perform the function test with a trained technician and qualified to function. The examinations will be conducted: Forced oscillation technique and spirometry, in that order.

Enrollment: 90 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Volunteers with Rheumatoid Arthritis for Patients Group;
• Volunteers without any respiratory disease for the control group.

Exclusion criteria

Smokers

Trial design

90 participants in 5 patient groups

Control Group

Description:

Group of nonsmokers individuals without respiratory disease.

RA patients 1

Description:

RA patients nonsmokers with up to five years of disease.

RA group 2

Description:

RA patients nonsmokers with six to ten years of disease.

RA group 3

Description:

RA patients nonsmokers with eleven to fifteen years of disease.

RA group 4

Description:

RA patients nonsmokers with sixteen or more years of disease